1.275
price up icon0.39%   0.005
 
loading
Cibus Inc stock is traded at $1.275, with a volume of 36,400. It is up +0.39% in the last 24 hours and down -2.67% over the past month. Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.27
Open:
$1.28
24h Volume:
36,400
Relative Volume:
0.07
Market Cap:
$97.32M
Revenue:
$4.29M
Net Income/Loss:
$-104.03M
P/E Ratio:
-0.6477
EPS:
-1.9685
Net Cash Flow:
$-50.65M
1W Performance:
+3.66%
1M Performance:
-2.67%
6M Performance:
-18.27%
1Y Performance:
-19.30%
1-Day Range:
Value
$1.27
$1.35
1-Week Range:
Value
$1.17
$1.35
52-Week Range:
Value
$1.09
$4.1907

Cibus Inc Stock (CBUS) Company Profile

Name
Name
Cibus Inc
Name
Phone
(858) 450-0008
Name
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Name
Employee
118
Name
Twitter
Name
Next Earnings Date
2026-05-14
Name
Latest SEC Filings
Name
CBUS's Discussions on Twitter

Compare CBUS vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
CBUS icon
CBUS
Cibus Inc
1.275 96.94M 4.29M -104.03M -50.65M -1.9685
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
449.73 114.33B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
611.46 64.47B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
878.90 54.99B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
278.34 38.42B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
155.46 34.03B 742.00K -1.37B -1.07B -7.0731

Cibus Inc Stock (CBUS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-29-24 Initiated Alliance Global Partners Buy
Jul-19-24 Resumed Canaccord Genuity Buy
Oct-09-23 Initiated H.C. Wainwright Buy
Jul-19-23 Resumed Canaccord Genuity Buy

Cibus Inc Stock (CBUS) Latest News

pulisher
Jun 10, 2026

Cibus names board member Craig Wichner as new CEO - MSN

Jun 10, 2026
pulisher
Jun 10, 2026

Cibus (CBUS) CEO receives 894K RSUs and 1.05M stock options grant - Stock Titan

Jun 10, 2026
pulisher
Jun 09, 2026

Cibus, Inc. Appoints Craig Wichner as CEO to Lead Next Phase of Growth and Innovation in Agricultural Biotechnology - Minichart

Jun 09, 2026
pulisher
Jun 09, 2026

Cibus Resets Leadership and Board to Drive Commercialization - TipRanks

Jun 09, 2026
pulisher
Jun 09, 2026

Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO - Stock Titan

Jun 09, 2026
pulisher
Jun 09, 2026

Cibus Names Board Member Craig Wichner as CEO - Moomoo

Jun 09, 2026
pulisher
Jun 09, 2026

Cibus appoints Craig Wichner as chief executive officer By Investing.com - Investing.com Australia

Jun 09, 2026
pulisher
Jun 08, 2026

Cibus (CBUS) Announces Leadership Changes - GuruFocus

Jun 08, 2026
pulisher
Jun 08, 2026

Cibus Appoints New CEO to Drive Commercialization - Intellectia AI

Jun 08, 2026
pulisher
Jun 08, 2026

Cibus appoints Craig Wichner as chief executive officer - Investing.com

Jun 08, 2026
pulisher
Jun 08, 2026

Cibus, Inc. Announces Leadership Transition with Appointment of Craig Wichner as CEO - Quiver Quantitative

Jun 08, 2026
pulisher
Jun 08, 2026

Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation - lincolnjournal.com

Jun 08, 2026
pulisher
Jun 06, 2026

Cibus Q1 earnings call highlights - MSN

Jun 06, 2026
pulisher
Jun 05, 2026

Cibus, Inc. 2026 Annual Meeting Results: Director Elections, Executive Compensation Approval, and Auditor Ratification (Form 8-K) – Minichart - Minichart

Jun 05, 2026
pulisher
Jun 05, 2026

Cibus Stockholders Approve Directors and Governance Measures - TipRanks

Jun 05, 2026
pulisher
Jun 05, 2026

Cibus (CBUS) 2026 meeting backs board slate, executive pay and BDO - Stock Titan

Jun 05, 2026
pulisher
Jun 04, 2026

Cibus (CBUS) director receives grant of 77,586 stock options - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Cibus (CBUS) director Moretti granted 77,586 options at $1.39 strike - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Stock option grant for Cibus (CBUS) director Rory B. Riggs - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Cibus (CBUS) director Gerhard Prante awarded 64,748 RSUs in equity grant - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Cibus (NASDAQ: CBUS) director awarded 64,748 RSUs in new stock grant - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Cibus (CBUS) director Kimberly Ann Box receives 77,586 stock options at $1.39 strike - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Cibus (CBUS) director Craig Wichner granted 77,586 stock options at $1.39 strike - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Director Urban Thomas awarded 64,748 Cibus (CBUS) shares in Form 4 filing - Stock Titan

Jun 04, 2026
pulisher
May 29, 2026

Cibus (CBUS) upgraded to buy: What does it mean for the stock? - MSN

May 29, 2026
pulisher
May 29, 2026

CBUS News | CIBUS INC (NASDAQ:CBUS) - ChartMill

May 29, 2026
pulisher
May 28, 2026

Cibus outlines runway into late Q1 2027 while shifting US rice launch to 2029 - MSN

May 28, 2026
pulisher
May 27, 2026

Cibus Global LLC (NASDAQ: CBUS) Share Price, CBUS Stock News, CBUS Share Price & Updates - Kalkine

May 27, 2026
pulisher
May 26, 2026

Cibus Inc. Q1 2026 Earnings: Narrowed Loss Surprises Estimates Amid Pre-Revenue ProgressEarnings Trend Analysis - The Legal Advocate

May 26, 2026
pulisher
May 26, 2026

[EFFECT] Cibus, Inc. SEC Filing - Stock Titan

May 26, 2026
pulisher
May 25, 2026

Cibus Inc. Q1 2026 Earnings: Narrowing Losses Amid Pre-Revenue PhaseAdjusted Earnings Analysis - The Legal Advocate

May 25, 2026
pulisher
May 25, 2026

Cibus Inc. (CBUS) Holds Steady at $1.38 as Consolidation Continues Near Support LevelsStock Buy Zone - The Legal Advocate

May 25, 2026
pulisher
May 22, 2026

Cibus (CBUS) registers 10.74M shares issuable on warrants — issuer to receive proceeds - Stock Titan

May 22, 2026
pulisher
May 22, 2026

Cibus (NASDAQ: CBUS) files at‑the‑market $50M shelf with Jefferies - Stock Titan

May 22, 2026
pulisher
May 21, 2026

Cibus Inc. (CBUS) Faces Selling Pressure as Shares Test Key Support ZoneOBV Breakout - The Legal Advocate

May 21, 2026
pulisher
May 20, 2026

CBUS SEC FilingsCIBUS INC 10-K, 10-Q, 8-K Forms - Stock Titan

May 20, 2026
pulisher
May 20, 2026

Cibus, Inc. (NASDAQ:CBUS) Q1 2026 Earnings Call Transcript - Insider Monkey

May 20, 2026
pulisher
May 19, 2026

Cibus Earnings Call: Cash Extended, Execution Critical - TipRanks

May 19, 2026
pulisher
May 18, 2026

CBUS Technical Analysis | Trend, Signals & Chart Patterns | CIBUS INC (NASDAQ:CBUS) - ChartMill

May 18, 2026
pulisher
May 17, 2026

MSN Money - MSN

May 17, 2026
pulisher
May 16, 2026

Number of shareholders of Cibus, Inc. – NASDAQ:CBUS - TradingView

May 16, 2026
pulisher
May 15, 2026

Cibus (CBUS) Q1 2026 Earnings: EPS -$0.33, Revenue $1.681M -- Bo - GuruFocus

May 15, 2026
pulisher
May 15, 2026

Cibus Inc to offer securities with aggregate initial offering price up to $200 millionSEC filing - marketscreener.com

May 15, 2026
pulisher
May 15, 2026

Cibus IncTo Offer Securities With Aggregate Initial Offering Price Up To $200 MillionSEC Filing - TradingView

May 15, 2026
pulisher
May 15, 2026

Cibus (CBUS) registers $200M shelf and $50M ATM via Jefferies - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Q1 2026 Cibus Inc Earnings Call Transcript - GuruFocus

May 15, 2026
pulisher
May 15, 2026

Cibus, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Adv - GuruFocus

May 15, 2026

Cibus Inc Stock (CBUS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$96.41
price down icon 1.61%
$29.82
price down icon 0.80%
$90.30
price down icon 0.33%
$53.94
price down icon 0.28%
ONC ONC
$264.43
price down icon 1.24%
$157.31
price down icon 1.95%
Cap:     |  Volume (24h):